Finafloxacin

Finafloxacin
Clinical data

Trade names	Xtoro
Identifiers
IUPAC name 8-Cyano-1-cyclopropyl-6-fluoro-7-[(4aS,7aS)-hexahydropyrrolo[3,4-b][1,4]oxazin-6(2H)-yl]-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid
CAS Number	209342-40-5
PubChem (CID)	11567473
ChemSpider	9742243
ChEBI	CHEBI:85176^Y
ChEMBL	CHEMBL1908370
Chemical and physical data
Formula	C₂₀H₁₉FN₄O₄
Molar mass	398.39 g/mol
3D model (Jmol)	Interactive image
SMILES C1CC1N2C=C(C(=O)C3=CC(=C(C(=C32)C#N)N4C[C@H]5[C@H](C4)OCCN5)F)C(=O)O
InChI InChI=1S/C20H19FN4O4/c21-14-5-11-17(25(10-1-2-10)7-13(19(11)26)20(27)28)12(6-22)18(14)24-8-15-16(9-24)29-4-3-23-15/h5,7,10,15-16,23H,1-4,8-9H2,(H,27,28)/t15-,16-/m0/s1 Key:FYMHQCNFKNMJAV-HOTGVXAUSA-N

Finafloxacin (Xtoro) is a fluoroquinolone antibiotic. In the United States, it is approved by the Food and Drug Administration to treat acute otitis externa (swimmer's ear) caused by the bacteria Pseudomonas aeruginosa and Staphylococcus aureus.^[1]

References

This article is issued from Wikipedia - version of the 4/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.